No use of the drug has received FDA approval as it can result in serious harm or death, Makary clarified. He emphasized the public must address the trend before it becomes the latest example of ...

A spokesperson for the FDA confirmed the plans in a statement to CBS News Tuesday, but did not respond to questions about when the review is scheduled to start and what exactly it will be ...

No illnesses have been reported in connection with the products, the FDA said. Need a break? Play the USA TODAY Daily Crossword Puzzle. The cucumbers, distributed by Fresh Start Produce Sales of ...

The petition aims to force the FDA to acknowledge robust clinical evidence and decades of mifepristone use that support the drug’s safety and efficacy. The move comes just one month after Health ...

As the race between Boston Mayor Michelle Wu and Josh Kraft heats up, dueling allegations of campaign finance violations took center stage this week. First, Boston Globe columnist Joan Vennochi ...

Kennedy, Jr. doubled down on his support for non-pharmaceutical health treatments during a recent podcast appearance, saying, “We’re going to end the war at the FDA against alternative ...

President Trump’s private golf club in Bedminster, N.J. was hit with a remarkable 18 health code violations, nine of them considered “critical,” according to a recent report by the Somerset ...

As alleged, UroGen stated that the ENVISION trial met its primary endpoint and that UroGen had reached "agreement with the FDA" that the ENVISION trial would support an NDA submission. In truth ...

fda.gov The Food and Drug Administration has updated a salmonella recall on tomatoes in three southern states to a Class I, the most severe category in which “a violative product will cause ...

A tomato recall due to risk of salmonella contamination has been designated with the U.S. Food and Drug Administration’s highest warning level. Plus, Jenna reveals the one thing her dad does ...

The FDA is reviewing linvoseltamab for the treatment of adult patients with relapsed/refractory (R/R) multiple myeloma who have received at least 4 prior lines of therapy or those who received 3 ...